Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruipeng Liang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Recent Patents on Anti-Cancer Drug Discovery|June 5, 2024
Regulation of Metastasis and Growth of Colorectal Cancer via Targeting the PTEN Pathway: An Update on the Progress of LncRNA MLLT4-AS1Ruipeng Liang, Zhili Liu, Bo Li, et al.
IEEE Transactions on Cybernetics|August 8, 2023
Dynamic Event-Triggered Synchronization of Markov Jump Neural Networks via Sliding Mode ControlJie Tao, Ruipeng Liang, Jiaxiang Su, et al.
Frontiers in Neurology|September 12, 2025
Exploration of heterogeneity in risk factors associated with imaging subtypes of white matter hyperintensities on fluid-attenuated inversion recovery magnetic resonance imagingYonglong Li, Xiufu Zhang, Haotian Wang, et al.
Frontiers in Oncology|November 13, 2025
Visualizing the vascular-cellular microenvironment in lung cancer brain metastasis via multiparametric fusion of DCE-MRI and DWIYonglong Li, Zhen Li, Haotian Wang, et al.
Frontiers in Oncology|March 11, 2026
Association of regional specificity of blood-brain barrier permeability with pathological subtypes in cerebral white matter of patients with non-brain metastatic lung cancerHaotian Wang, Jian Zeng, Zhengzhen Li, et al.
Gene|September 3, 2019
The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysisWenTing Xie, Han Zhang, ShanShan Qin, et al.
Journal of Medicinal Chemistry|September 8, 2020
Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable DruggabilityTong Zhao, Qing Meng, Zhuosen Sun, et al.
Journal of Medicinal Chemistry|January 27, 2022
Discovery of Novel Bicyclic Imidazolopyridine-Containing Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Improved Efficacy and Favorable DruggabilityTong Zhao, Jian Zhang, Yucen Tao, et al.
European Journal of Medicinal Chemistry|October 11, 2022
Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitorsJian Zhang, Yue Dong, Shenghua Gao, et al.
Experimental and Therapeutic Medicine|November 28, 2019
Expression and potential prognostic value of histone family gene signature in breast cancerWenting Xie, Jiajia Zhang, Peng Zhong, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Recent Patents on Anti-Cancer Drug Discovery|June 5, 2024
Regulation of Metastasis and Growth of Colorectal Cancer via Targeting the PTEN Pathway: An Update on the Progress of LncRNA MLLT4-AS1Ruipeng Liang, Zhili Liu, Bo Li, et al.
IEEE Transactions on Cybernetics|August 8, 2023
Dynamic Event-Triggered Synchronization of Markov Jump Neural Networks via Sliding Mode ControlJie Tao, Ruipeng Liang, Jiaxiang Su, et al.
Frontiers in Neurology|September 12, 2025
Exploration of heterogeneity in risk factors associated with imaging subtypes of white matter hyperintensities on fluid-attenuated inversion recovery magnetic resonance imagingYonglong Li, Xiufu Zhang, Haotian Wang, et al.
Frontiers in Oncology|November 13, 2025
Visualizing the vascular-cellular microenvironment in lung cancer brain metastasis via multiparametric fusion of DCE-MRI and DWIYonglong Li, Zhen Li, Haotian Wang, et al.
Frontiers in Oncology|March 11, 2026
Association of regional specificity of blood-brain barrier permeability with pathological subtypes in cerebral white matter of patients with non-brain metastatic lung cancerHaotian Wang, Jian Zeng, Zhengzhen Li, et al.
Gene|September 3, 2019
The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysisWenTing Xie, Han Zhang, ShanShan Qin, et al.
Journal of Medicinal Chemistry|September 8, 2020
Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable DruggabilityTong Zhao, Qing Meng, Zhuosen Sun, et al.
Journal of Medicinal Chemistry|January 27, 2022
Discovery of Novel Bicyclic Imidazolopyridine-Containing Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Improved Efficacy and Favorable DruggabilityTong Zhao, Jian Zhang, Yucen Tao, et al.
European Journal of Medicinal Chemistry|October 11, 2022
Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitorsJian Zhang, Yue Dong, Shenghua Gao, et al.
Experimental and Therapeutic Medicine|November 28, 2019
Expression and potential prognostic value of histone family gene signature in breast cancerWenting Xie, Jiajia Zhang, Peng Zhong, et al.
Pageof 2